These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6761080)

  • 1. Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
    Dalhoff A; Gehl AE; Gau W; Lode H
    Chemotherapy; 1982; 28(6):444-53. PubMed ID: 6761080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
    Dalhoff A; Gehl AE; Lode H
    Chemotherapy; 1982; 28(5):381-9. PubMed ID: 6754281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of mezlocillin and cefoxitin against Proteus morganii in the granuloma pouch model.
    Dalhoff A
    Eur J Clin Microbiol; 1982 Aug; 1(4):243-7. PubMed ID: 6217067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of interaction between immunoglobulin G and mezlocillin against beta-lactamase producing bacteria.
    Dalhoff A; Brunner H
    Arzneimittelforschung; 1983; 33(12):1666-71. PubMed ID: 6607736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
    Araki H; Minami S; Watanabe Y; Yasuda T
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1131-6. PubMed ID: 1929254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducer activity of beta-lactam antibiotics for the beta-lactamases of Proteus rettgeri and Proteus vulgaris.
    Yotsuji A; Minami S; Araki Y; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1982 Nov; 35(11):1590-3. PubMed ID: 6761329
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
    Ikeda Y; Nishino T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial antagonism of beta-lactam antibiotics in experimental infections.
    Kasai K
    Chemotherapy; 1986; 32(2):148-58. PubMed ID: 3516593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
    Yoshida T; Kazuno Y; Shomura T; Murata S; Inouye S; Ito T
    J Antibiot (Tokyo); 1986 Jul; 39(7):956-65. PubMed ID: 3531130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
    Wildfeuer A; Schmalreck A; Räder K; Eibel G; Pfaff G
    Arzneimittelforschung; 1989 Jan; 39(1):94-100. PubMed ID: 2785802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
    Ikeda Y; Nishino T; Tanino T
    Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between acylureidopenicillins and immunoglobulin G in experimental animals.
    Dalhoff A
    Am J Med; 1984 Mar; 76(3A):91-100. PubMed ID: 6424463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of beta-lactamase induction in Pseudomonas aeruginosa.
    Dalhoff A; Cullmann W
    J Antimicrob Chemother; 1984 Oct; 14(4):349-57. PubMed ID: 6438044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.
    Ikeda Y; Fukuoka Y; Motomura K; Yasuda T; Nishino T
    Antimicrob Agents Chemother; 1990 Jan; 34(1):94-7. PubMed ID: 2183712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro microbiological properties of mezlocillin compared with four cephalosporins.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Aug; 5(4):273-7. PubMed ID: 3490314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of beta-lactamase in Proteus vulgaris.
    Okonogi K; Kuno M; Higashide E
    J Gen Microbiol; 1986 Jan; 132(1):143-50. PubMed ID: 3519851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.